Detalhe da pesquisa
1.
Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial.
Lancet Oncol;
25(5): 649-657, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38608694
2.
Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial.
Lancet Oncol;
25(5): 658-667, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38608693
3.
Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry.
Endocr Pract;
30(1): 25-30, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37858722
4.
New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach.
Curr Oncol Rep;
24(1): 89-98, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35061191
5.
Mechanical Disturbance of Osteoclasts Induces ATP Release That Leads to Protein Synthesis in Skeletal Muscle through an Akt-mTOR Signaling Pathway.
Int J Mol Sci;
23(16)2022 Aug 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36012713
6.
Epidemiological risk factors for adrenocortical carcinoma: A hospital-based case-control study.
Int J Cancer;
146(7): 1836-1840, 2020 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31241762
7.
Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women.
Cancer;
126(11): 2607-2613, 2020 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32125711
8.
Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients.
Ophthalmic Plast Reconstr Surg;
35(1): 50-52, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29927883
9.
Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma.
Ann Surg;
268(1): 172-178, 2018 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28257320
10.
Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma.
Ann Surg Oncol;
25(5): 1395-1402, 2018 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29427212
11.
Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress.
Curr Oncol Rep;
19(12): 83, 2017 Oct 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29081018
12.
Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: a case report.
Clin Cases Miner Bone Metab;
14(3): 340-346, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29354165
13.
Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer.
Oncologist;
19(5): 477-82, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24733667
14.
Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre.
Clin Endocrinol (Oxf);
80(3): 342-7, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24033606
15.
Impact of surgical resection for subdiaphragmatic paragangliomas.
World J Surg;
38(3): 733-41, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24390286
16.
Clinical and radiologic features of pheochromocytoma/ganglioneuroma composite tumors: a case series with comparative analysis.
Endocr Pract;
20(9): 864-9, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24641930
17.
High-Specific-Activity 131I-MIBG for the Treatment of Advanced Pheochromocytoma and Paraganglioma.
Clin Nucl Med;
2024 Apr 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38630996
18.
Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.
Curr Oncol Rep;
15(4): 356-71, 2013 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23674235
19.
Functional Imaging Evidence of Tumor Response to High-Specific-Activity 131 I-MIBG Therapy in an 84-Year-Old Patient With Metastatic Pheochromocytoma/Paraganglioma.
Clin Nucl Med;
48(5): 426-427, 2023 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36728291
20.
Proposed MIBG Scan-Based Tumor Response Criteria of High-Specific-Activity 131 I-MIBG Therapy in Metastatic Pheochromocytoma/Paraganglioma.
Clin Nucl Med;
48(4): 320-323, 2023 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36758558